Hutch News

Hutch News

Stories tagged 'Transplant and Immunotherapy'

Forbes ’30 Under 30’ lists Hutch immunotherapy researcher Alex Salter

Grad student on short list of young health care influencers

Nov. 14, 2018 | by Susan Keown / Fred Hutch News Service

For his research on cancer immunotherapy, Hutch grad student Alex Salter was named one of the top young health care innovators in the U.S. and Canada.

View story >


Hutch science featured at world's premier cancer immunotherapy meeting

Researchers honored at SITC 2018 for work on immune-based treatments for leukemia, ovarian cancer, skin cancer

Nov. 14, 2018 | By Susan Keown / Fred Hutch News Service

Fred Hutch's Drs. Philip Greenberg, Kristin Anderson and Kelly Paulson were honored Nov. 10 at the annual meeting of the Society for Immunotherapy of Cancer in Washington, D.C.

View story >


Dr. Matthias Stephan named Allen Distinguished Investigator

The $1.5 million award will help translate cutting-edge nanoparticle immunotherapy approach to the clinic

Oct. 30, 2018 | By Sabrina Richards / Fred Hutch News Service

Fred Hutch immunobioengineer Dr. Matthias Stephan, who is developing the use of immune-cell-programming nanoparticles as a cancer treatment, has been named a 2018 Allen Distinguished Investigator by The Paul G. Allen Frontiers Group.

View story >


Dr. Joachim Deeg named Miklos Kohary and Natalia Zimonyi Kohary Endowed Chair for Cancer Research

Endowment will support future research for myelodysplastic syndromes

Oct. 18, 2018 | By Sabrina Richards / Fred Hutch News Service

Dr. Joachim Deeg, a clinical researcher at Fred Hutch who studies myelodysplastic syndromes, has been named the Miklos and Natalia Zimonyi Kohary Endowed Chair for Cancer Research.

View story >


Standard myeloma treatment reveals itself as an immunotherapy

Mouse study shows how transplanting patients’ own healthy blood stem cells can curb cancer, opening door to better treatments

Oct. 9, 2018 | By Susan Keown / Fred Hutch News Service

Despite conventional wisdom, a standard treatment for myeloma — autologous transplant — may be a type of immunotherapy, new research shows.

View story >


Revealing a new way that cancer can evade immunotherapy — and, maybe, how to stop it

How a new technology solved a mystery and honors one man’s legacy

Sept. 24, 2018 | by Susan Keown / Fred Hutch News Service

Before his aggressive cancer took his life, he donated his tissue samples to research. Now scientists think that new insights from his cells could save lives.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.